1. Sarne, Yosef. The dual neuroprotective-neurotoxic profile of cannabinoid drugs. BRITISH JOURNAL OF PHARMACOLOGY, AUG 2011.
2. The endocannabinoid system as a target for the treatment of neuronal damage Author(s): Fernandez-Ruiz J, Garcia C, Sagredo O, et al. Source: EXPERT OPINION ON THERAPEUTIC TARGETS Volume: 14 Issue: 4 Pages: 387-404 Published: APR 2010
3. The neuroprotective properties of palmitoylethanolamine against oxidative stress in a neuronal cell line Author(s): Duncan RS, Chapman KD, Koulen P Source: MOLECULAR NEURODEGENERATION Volume: 4 Article Number: 50 Published: DEC 10 2009
4. Adenosine A(2A) receptors enable the synaptic effects of cannabinoid CB1 receptors in the rodent striatum Author(s): Tebano MT, Martire A, Chiodi V, et al. Source: JOURNAL OF NEUROCHEMISTRY Volume: 110 Issue: 6 Pages: 1921-1930 Published: SEP 2009
5. Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats Author(s): Marchalant Y, Cerbai F, Brothers HM, et al. Source: NEUROBIOLOGY OF AGING Volume: 29 Issue: 12 Pages: 1894-1901 Published: DEC 2008
6. Role of cannabinoids and endocannabinoids in cerebral ischemia Author(s): Hillard CJ Source: CURRENT PHARMACEUTICAL DESIGN Volume: 14 Issue: 23 Pages: 2347-2361 Published: AUG 2008
7. Regulation of neurite outgrowth by G(i/o) signaling pathways Author(s): Bromberg KD, Iyengar R, He JC Source: FRONTIERS IN BIOSCIENCE Volume: 13 Pages: 4544-4557 Published: MAY 2008
8. Cannabinoid modulation of neuronal function after oxygen/glucose deprivation in area CA1 of the rat hippocampus Author(s): Youssef FF, Hormuzdi SG, Irving AJ, et al. Source: NEUROPHARMACOLOGY Volume: 52 Issue: 6 Pages: 1327-1335 Published: MAY 2007
9. Hermann D, Sartorius A, Welzel H, et al. Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users BIOLOGICAL PSYCHIATRY 61 (11): 1281-1289 JUN 1 2007
10. Marchalant Y, Rosi S, Wenk GL Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation NEUROSCIENCE 144 (4): 1516-1522 FEB 23 2007
11. Gilbert GL, Kim HJ, Waataja JJ, et al. Delta(9)-Tetrahydrocannabinol protects hippocampal neurons from excitotoxicity BRAIN RESEARCH 1128 (1): 61-69 JAN 12 2007
12. Fumagalli F, Racagni G, Riva MA The expanding role of BDNF: a therapeutic target for Alzheimer's disease? PHARMACOGENOMICS JOURNAL 6 (1): 8-15 JAN-FEB 2006
13. Fumagalli F, Racagni G, Riva MA Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease PHARMACOGENOMICS JOURNAL 6 (2): 95-104 MAR-APR 2006
14. Gouzoulis-Mayfrank E, Daumann J The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview JOURNAL OF PSYCHOPHARMACOLOGY 20 (2): 188-193 MAR 2006
15. Kim SH, Won SJ, Mao XO, et al. Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity MOLECULAR PHARMACOLOGY 69 (3): 691-696 MAR 2006
16. de Ceballos ML, Guzman M The role of cannabinoids in preventing the neurodegenerative process occurring in Alzheimer's disease DRUG FUTURE 30 (8): 807-814 AUG 2005
17. Hill MN, Gorzalka BB Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression? BEHAV PHARMACOL 16 (5-6): 333-352 SEP 2005
18. Chen J, Lee CT, Errico S, et al. Protective effects of Delta(9)-tetrahydrocannabinol against N-methyl-D-aspartate-induced AF5 cell death MOL BRAIN RES 134 (2): 215-225 APR 4 2005
19. Kim SH, Won SJ, Mao XO, et al. Involvement of protein kinase A in cannabinoid receptor-mediated protection from oxidative neuronal injury J PHARMACOL EXP THER 313 (1): 88-94 APR 2005
20. Ramirez BG, Blazquez C, del Pulgar TG, et al. Prevention of Alzheimer's disease pathology by cannabinoids: Neuroprotection mediated by blockade of microglial activation J NEUROSCI 25 (8): 1904-1913 FEB 23 2005
21. Jackson SJ, Baker D, Cuzner ML, et al. Cannabinoid-mediated neuroprotection following interferon-gamma treatment in a three-dimensional mouse brain aggregate cell culture EUR J NEUROSCI 20 (9): 2267-2275 NOV 2004
22. Venderova K, Ruzicka E, Vorisek V, et al. Survey on cannabis use in Parkinson's disease: Subjective improvement of motor symptoms MOVEMENT DISORD 19 (9): 1102-1106 SEP 2004
23. Sarne Y, Keren O Are cannabinoid drugs neurotoxic or neuroprotective? MED HYPOTHESES 63 (2): 187-192 2004
24. Drysdale AJ, Platt B Cannabinoids: Mechanisms and therapeutic applications in the CNS CURR MED CHEM 10 (24): 2719-2732 DEC 2003
25. Nilsson O, Jacobsson SOP, Fowler CJ Cannabinoid CB1 receptor activation does not prevent the toxicity of glutamate towards embryonic chick telencephalon primary cultures COMP BIOCHEM PHYS C 136 (3): 245-251 NOV 2003
26. Leker RR, Gai N, Mechoulam R, et al. Drug-induced hypothermia reduces ischemic damage - Effects of the cannabinoid HU-210 STROKE 34 (8): 2000-2006 AUG 2003
27. van der Stelt M, Hansen HH, Veldhuis WB, et al. Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases NEUROTOX RES 5 (3): 183-199 2003
28. Fowler CJ  Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents - Non-psychoactive cannabinoids, 'entourage' compounds and inhibitors of N-acyl ethanolarnine breakdown as therapeutic strategies to avoid pyschotropic effects BRAIN RES REV 41 (1): 26-43 JAN 2003
29. van der Stelt M, Veldhuis WB, Maccarrone M, et al. Acute neuronal injury, excitotoxicity, and the endocannabinoid system MOL NEUROBIOL 26 (2-3): 317-346 OCT-DEC 2002
30. Guzman M, Sanchez C, Galve-Roperh I  Cannabinoids and cell fate PHARMACOL THERAPEUT 95 (2): 175-184 AUG 2002
31. Lambert DM, Vandevoorde S, Jonsson KO, et al. The palmitoylethanolamide family: A new class of anti-inflammatory agents? CURR MED CHEM 9 (6): 663-674 MAR 2002
32. Marsicano G, Moosmann B, Hermann H, et al. Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1 J NEUROCHEM 80: (3) 448-456 FEB 2002